HK1211918A1 - Coumarin derivative - Google Patents
Coumarin derivativeInfo
- Publication number
- HK1211918A1 HK1211918A1 HK15112624.2A HK15112624A HK1211918A1 HK 1211918 A1 HK1211918 A1 HK 1211918A1 HK 15112624 A HK15112624 A HK 15112624A HK 1211918 A1 HK1211918 A1 HK 1211918A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- coumarin derivative
- coumarin
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012208656 | 2012-09-21 | ||
PCT/JP2013/075414 WO2014046224A1 (ja) | 2012-09-21 | 2013-09-20 | クマリン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211918A1 true HK1211918A1 (en) | 2016-06-03 |
Family
ID=50341526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112624.2A HK1211918A1 (en) | 2012-09-21 | 2015-12-23 | Coumarin derivative |
Country Status (15)
Country | Link |
---|---|
US (1) | US9365533B2 (xx) |
EP (1) | EP2899187B1 (xx) |
JP (1) | JP6091016B2 (xx) |
KR (1) | KR20150056544A (xx) |
CN (1) | CN104640849B (xx) |
AU (1) | AU2013318962B2 (xx) |
BR (1) | BR112015005973A2 (xx) |
CA (1) | CA2885262A1 (xx) |
ES (1) | ES2630068T3 (xx) |
HK (1) | HK1211918A1 (xx) |
IL (1) | IL237823A (xx) |
RU (1) | RU2646756C2 (xx) |
SG (1) | SG11201502149YA (xx) |
TW (1) | TWI583677B (xx) |
WO (1) | WO2014046224A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106232116B (zh) * | 2014-03-20 | 2020-05-01 | 日本脏器制药株式会社 | 含有香豆素衍生物作为有效成分的治疗或预防剂 |
JP6089055B2 (ja) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | クマリン誘導体を含有する医薬 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1523317A (fr) * | 1967-03-20 | 1968-05-03 | Lipha | Nouveaux dérivés hydroxylés de la coumarine et leurs procédés de préparation |
FR2543140B1 (fr) * | 1983-03-24 | 1985-06-21 | Cortial | Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique |
RU2036917C1 (ru) * | 1989-11-28 | 1995-06-09 | Санкио Компани Лимитед | Производные кумарина или их фармацевтически приемлемая соль |
CA2089372A1 (en) * | 1990-09-28 | 1993-03-25 | Pharmacia & Upjohn Company | Anthelmintic and anticoccidial 3-carbamoyl-4-hydroxycoumarins, method of use and compositions |
US5922755A (en) | 1993-04-09 | 1999-07-13 | Toyama Chemical Co., Ltd. | Immunomodulator, cell adhesion inhibtor, and agent for treating, and preventing autoimmune diseases |
EP0807629B1 (de) * | 1996-05-15 | 2004-03-03 | Aventis Pharma Deutschland GmbH | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US6191164B1 (en) * | 1996-05-15 | 2001-02-20 | Hoechst Aktiengesellschaft | Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
JP4658512B2 (ja) * | 2004-04-27 | 2011-03-23 | 日本臓器製薬株式会社 | クマリン誘導体及び該誘導体を含有するメイラード反応阻害剤 |
DE102004063910B4 (de) * | 2004-07-05 | 2006-12-28 | Bioplanta Arzneimittel Gmbh | Trisubstituierte Benzopyranone sowie diese enthaltende Pflanzenextrakte und Mittel |
WO2009014100A1 (ja) * | 2007-07-20 | 2009-01-29 | Chugai Seiyaku Kabushiki Kaisha | p27蛋白質誘導剤 |
-
2013
- 2013-09-18 TW TW102133808A patent/TWI583677B/zh not_active IP Right Cessation
- 2013-09-20 US US14/429,300 patent/US9365533B2/en active Active
- 2013-09-20 AU AU2013318962A patent/AU2013318962B2/en not_active Ceased
- 2013-09-20 RU RU2015114480A patent/RU2646756C2/ru not_active IP Right Cessation
- 2013-09-20 ES ES13838182.7T patent/ES2630068T3/es active Active
- 2013-09-20 WO PCT/JP2013/075414 patent/WO2014046224A1/ja active Application Filing
- 2013-09-20 SG SG11201502149YA patent/SG11201502149YA/en unknown
- 2013-09-20 CN CN201380048855.5A patent/CN104640849B/zh active Active
- 2013-09-20 EP EP13838182.7A patent/EP2899187B1/en active Active
- 2013-09-20 CA CA2885262A patent/CA2885262A1/en not_active Abandoned
- 2013-09-20 JP JP2014536924A patent/JP6091016B2/ja active Active
- 2013-09-20 KR KR1020157006140A patent/KR20150056544A/ko active IP Right Grant
- 2013-09-20 BR BR112015005973A patent/BR112015005973A2/pt not_active IP Right Cessation
-
2015
- 2015-03-19 IL IL237823A patent/IL237823A/en active IP Right Grant
- 2015-12-23 HK HK15112624.2A patent/HK1211918A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
TW201418239A (zh) | 2014-05-16 |
RU2015114480A (ru) | 2016-11-10 |
JPWO2014046224A1 (ja) | 2016-08-18 |
ES2630068T3 (es) | 2017-08-17 |
TWI583677B (zh) | 2017-05-21 |
US20150232440A1 (en) | 2015-08-20 |
CA2885262A1 (en) | 2014-03-27 |
US9365533B2 (en) | 2016-06-14 |
SG11201502149YA (en) | 2015-05-28 |
WO2014046224A1 (ja) | 2014-03-27 |
BR112015005973A2 (pt) | 2017-07-04 |
EP2899187B1 (en) | 2017-04-19 |
CN104640849A (zh) | 2015-05-20 |
JP6091016B2 (ja) | 2017-03-08 |
AU2013318962A1 (en) | 2015-04-16 |
RU2646756C2 (ru) | 2018-03-07 |
EP2899187A4 (en) | 2016-06-29 |
IL237823A (en) | 2017-05-29 |
CN104640849B (zh) | 2016-10-26 |
EP2899187A1 (en) | 2015-07-29 |
KR20150056544A (ko) | 2015-05-26 |
AU2013318962B2 (en) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
PT2844659T (pt) | Derivados de pirrolotriazinona | |
HK1207363A1 (en) | Novel indanesulfamide derivative | |
AP2015008347A0 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
HK1208817A1 (en) | Chromane compounds | |
HK1200824A1 (en) | Substituted phenylazole derivative | |
HK1197062A1 (en) | Chromene compound | |
PT2873660T (pt) | Derivado de indolecarboxamida | |
EP2821404A4 (en) | CHROMANE DERIVATIVE | |
EP2842958A4 (en) | NAPHTHOBISTHIADIAZOLDERIVAT | |
SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
HK1211918A1 (en) | Coumarin derivative | |
HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- |